Getting to Complete Response With Less Toxicity in HER2-Positive Early Breast Cancer
(MedPage Today) -- In the DESTINY-Breast11 (DB11) trial, trastuzumab deruxtecan (T-DXd, Enhertu), followed by the taxane paclitaxel (Taxol), trastuzumab (Herceptin), and pertuzumab (Perjeta) in combination (THP), improved pathologic complete response...
Read more »
Medical Industry news
Roy Herbst, MD, PhD, on Why It Is an 'Exciting Time' in Oncology and Hematology
Managing Weight in COPD
How Did Physicians in Congress Vote on the 'Big Beautiful Bill'?
Statins Suggested for Preventing Subarachnoid Hemorrhage
Caffeine and Osteoporosis; WW Looks to Menopause; Boosting Endo Fellowship Interest
Switch to Dry-Powder Inhaler Worsened COPD, Asthma Patient Outcomes
Impella Controller Flaw; New Coronary Calcium Score; Cardiologist Killed in Gaza
The Worst of Trump's 'Big Beautiful Bill' Will Be Felt in Rural America
RFK Jr. Promoted Food Company He Says Is Healthy. Their Meals Are Ultra-Processed.
Nearly Half of Teen Vapers Have Recently Tried to Quit
Locked Guns Tied to Lower Firearm Suicide Risk Among Teens
M&M's vs RFK Jr.; Workplace Mental Health at Risk; Coffee Enema Warning
Multilevel Intervention Increased HPV Vaccination for Most Children
American Kids' Health Has Been Declining, Study Finds
